Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases

Clinical trial NCT00936975 · COMPLETED

Trial details

NCT number: NCT00936975
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone-Resistant Prostate Cancer Metastatic Malignant Neoplasm in the Bone Recurrent Prostate Carcinoma Stage IV Prostate Cancer

Start date: 2009-09-01
Primary completion: 2014-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.